Seminars in Oncology
Volume 35, Issue 1 , Pages 51-63, February 2008

Evolving Role of Imaging Modalities in Inflammatory Breast Cancer

  • Carisa H. Le-Petross

      Affiliations

    • Department of Diagnostic Radiology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.
  • ,
  • Luc Bidaut

      Affiliations

    • Department of Imaging Physics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.
  • ,
  • Wei T. Yang

      Affiliations

    • Department of Diagnostic Radiology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.
    • Corresponding Author InformationAddress correspondence to Wei T. Yang, MD, Department of Diagnostic Radiology, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.

Imaging plays several key roles in the diagnosis and assessment of inflammatory breast cancer (IBC). These include characterization of the known tumor, delineation of locoregional disease in the ipsilateral and contralateral breast and regional lymph node basins, diagnosis of distant metastases, and evaluation of treatment response. We review the role of conventional imaging modalities, including mammography and sonography. We also discuss the potential of using evolving imaging modalities such as magnetic resonance imaging (MRI), positron emission tomography with computed tomography (PET/CT), and more advanced or emerging imaging techniques in the assessment of IBC.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(07)00241-2

doi:10.1053/j.seminoncol.2007.11.016

Seminars in Oncology
Volume 35, Issue 1 , Pages 51-63, February 2008